|
1
|
Kawamura A, Baitsch D, Telgmann R,
Feuerborn R, Weissen-Plenz G, Hagedorn C, Saku K, Brand-Herrmann
SM, von Eckardstein A, Assmann G and Nofer JR: Apolipoprotein E
interrupts interleukin-1beta signaling in vascular smooth muscle
cells. Arterioscler Thromb Vasc Biol. 27:1610–1017. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yearley JH, Xia D, Pearson CB, Carville A,
Shannon RP and Mansfield KG: Interleukin-18 predicts
atherosclerosis progression in SIV-infected and uninfected rhesus
monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet. Lab
Invest. 89:657–667. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galea J, Armstrong J, Gadsdon P, Holden H,
Francis SE and Holt CM: Interleukin-1 beta in coronary arteries of
patients with ischemic heart disease. Arterioscler Thromb Vasc
Biol. 16:1000–1016. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhaskar V, Yin J, Mirza AM, Phan D,
Vanegas S, Issafras H, Michelson K, Hunter JJ and Kantak SS:
Monoclonal antibodies targeting IL-1 beta reduce biomarkers of
atherosclerosis in vitro and inhibit atherosclerotic plaque
formation in apolipoprotein E-deficient mice. Atherosclerosis.
216:313–320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Nardo D and Latz E: NLRP3 inflammasomes
link inflammation and metabolic disease. Trends Immunol.
32:373–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Xu S, Jiang B, Cohen RA and Zang M:
Activation of sterol regulatory element binding protein and NLRP3
inflammasome in atherosclerotic lesion development in diabetic
pigs. PLoS One. 8:e675322013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zheng F, Xing S, Gong Z, Mu W and Xing Q:
Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques
in apolipoprotein E-deficient mice. Mediators Inflamm.
2014:5072082014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Satoh M, Tabuchi T, Itoh T and Nakamura M:
NLRP3 inflammasome activation in coronary artery disease: Results
from prospective and randomized study of treatment with
atorvastatin or rosuvastatin. Clin Sci (Lond). 126:233–241. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang K, Zhang XJ, Cao LJ, Liu XH, Liu ZH,
Wang XQ, Chen QJ, Lu L, Shen WF and Liu Y: Toll-like receptor 4
mediates inflammatory cytokine secretion in smooth muscle cells
induced by oxidized low-density lipoprotein. PLoS One.
9:e959352014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yin YW, Liao SQ, Zhang MJ, Liu Y, Li BH,
Zhou Y, Chen L, Gao CY, Li JC and Zhang LL: TLR4-mediated
inflammation promotes foam cell formation of vascular smooth muscle
cell by upregulatng ACAT1 expression. Cell Death Dis. 6:16592015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barton GM and Medzhitov R: Toll-like
receptor signaling pathways. Science. 300:1524–1525. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang JM, Zhang GN, Shi Y, Zha X, Zhu Y,
Wang MM, Lin Q, Wang W, Lu HY, Ma SQ, et al: Atractylenolide-I
sensitizes human ovarian cancer cells to paclitaxel by blocking
activation of TLR4/MyD88-dependent pathway. Sci Rep. 4:38402014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu ZP, Fang XL, Fang N, Wang XB, Qian HY,
Cao Z, Cheng Y, Wang BN and Wang Y: Melatonin ameliorates vascular
endothelial dysfunction, inflammation, and atherosclerosis by
suppressing the TLR4/NF-κB system in high-fat-fed rabbits. J Pineal
Res. 55:388–398. 2013.PubMed/NCBI
|
|
14
|
Shang T, Ran F, Qiao Q, Liu Z and Liu CJ:
Tanshinone IIA attenuates elastase-induced AAA in rats via
inhibition of MyD88-dependent TLR-4 signaling. Vasa. 43:39–46.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang G, Bao P, Zhang L, Lyu Z, Zhou B,
Chen K, Peng S, Wang Y, Yao L, Zhou Y and Li Y: Critical role of
myeloid differentiation factor 88 in necrotizing enterocolitis.
Pediatr Res. 75:707–715. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bauernfeind FG, Horvath G, Stutz A,
Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks
BG, Fitzgerald KA, et al: Cutting edge: NF-kappaB activating
pattern recognition and cytokine receptors license NLRP3
inflammasome activation by regulatng NLRP3 expression. J Immunol.
183:787–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bauernfeind F, Bartok E, Rieger A, Franchi
L, Núñez G and Hornung V: Cutting edge: Reactive oxygen species
inhibitors block priming, but not activation, of the NLRP3
inflammasome. J Immunol. 187:613–617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ikram M: A review on the chemical and
pharmacological aspects of genus Berberis. Planta Med. 28:353–358.
1975. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chung JG, Wu LT, Chu CB, Jan JY, Ho CC,
Tsou MF, Lu HF, Chen GW, Lin JG and Wang TF: Effects of berberine
on arylamine N-acetyltransferase activity in human bladder tumour
cells. Food Chem Toxicol. 37:319–326. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang C, Zhang Y, Gong Z, Sheng X, Li Z,
Zhang W and Qin Y: Berberine inhibits 3T3-L1 adipocyte
differentiation through the PPARgamma pathway. Biochem Biophys Res
Commun. 348:571–578. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang XX, Yan HM, Xu Q, Xia MF, Bian H,
Zhu TF and Gao X: The effects of berberine on hyperhomocysteinemia
and hyperlipidemia in rats fed with a long-term high-fat diet.
Lipids Health Dis. 11:862012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang Z, Meng S, Wang L, Wang Y, Chen T
and Wang C: Suppression of oxLDL-induced MMP-9 and EMMPRIN
expression by berberine via inhibition of NF-κB activation in human
THP-1 macrophages. Anat Rec (Hoboken). 295:78–86. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang Z, Dong F, Li S, Chu M, Zhou H, Lu Z
and Huang W: Berberine-induced inhibition of adipocyte
enhancer-binding protein 1 attenuates oxidized low-density
lipoprotein accumulation and foam cell formation in phorbol
12-myristate 13-acetate-induced macrophages. Eur J Pharmacol.
690:164–169. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsuchiya S, Kobayashi Y, Goto Y, Okumura
H, Nakae S, Konno T and Tada K: Induction of maturation in cultured
human monocytic leukemia cells by a phorbol diester. Cancer Res.
42:1530–1536. 1982.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Z, Wang C, Wei L, Wang J, Fan Y,
Wang L, Wang Y and Chen T: Resveratrol inhibits EMMPRIN expression
via P38 and ERK1/2 pathways in PMA-induced THP-1 cells. Biochem
Biophys Res Commun. 374:517–521. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang Z, Wang L, Meng S, Wang Y, Chen T
and Wang C: Berberine reduces both MMP-9 and EMMPRIN expression
through prevention of p38 pathway activation in PMA-induced
macrophages. Int J Cardiol. 146:153–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takeuchi O and Akira S: Pattern
recognition receptors and inflammation. Cell. 140:805–820. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ridker PM, Everett BM, Thuren T, MacFadyen
JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker
SD, et al: Antiinflammatory therapy with canakinumab for
atherosclerotic disease. N Engl J Med. 377:1119–1131. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kirii H, Niwa T, Yamada Y, Wada H, Saito
K, Iwakura Y, Asano M, Moriwaki H and Seishima M: Lack of
interleukin-1beta decreases the severity of atherosclerosis in
ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 23:656–660.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Merhi-Soussi F, Kwak BR, Magne D,
Chadjichristos C, Berti M, Pelli G, James RW, Mach F and Gabay C:
Interleukin-1 plays a major role in vascular inflammation and
atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc
Res. 66:583–593. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alexander MR, Moehle CW, Johnson JL, Yang
Z, Lee JK, Jackson CL and Owens GK: Genetic inactivation of IL-1
signaling enhances atherosclerotic plaque instability and reduces
outward vessel remodeling in advanced atherosclerosis in mice. J
Clin Invest. 122:70–79. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eder C: Mechanisms of interleukin-1beta
release. Immunobiology. 214:543–553. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lopez-Castejon G and Brough D:
Understanding the mechanism of IL-1β secretion. Cytokine Growth
Factor Rev. 22:189–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dinarello CA: Immunological and
inflammatory functions of the interleukin-1 family. Annu Rev
Immunol. 27:519–550. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wilson KP, Black JA, Thomson JA, Kim EE,
Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck
SA, et al: Structure and mechanism of interleukin-1 beta converting
enzyme. Nature. 370:270–275. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou R, Tardivel A, Thorens B, Choi I and
Tschopp J: Thioredoxin-interacting protein links oxidative stress
to inflammasome activation. Nat Immunol. 11:136–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Duewell P, Kono H, Rayner KJ, Sirois CM,
Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr
M, et al: NLRP3 inflammasomes are required for atherogenesis and
activated by cholesterol crystals. Nature. 464:1357–1361. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vandanmagsar B, Youm YH, Ravussin A,
Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM and Dixit
VD: The NLRP3 inflammasome instigates obesity-induced inflammation
and insulin resistance. Nat Med. 17:179–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Leemans JC, Cassel SL and Sutterwala FS:
Sensing damage by the NLRP3 inflammasome. Immunol Rev. 243:152–162.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Choi SH, Cho SK, Kang SS, Bae CS, Bai YH,
Lee SH and Pak SC: Effect of apitherapy in piglets with preweaning
diarrhea. Am J Chin Med. 31:321–326. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Q, Zhang M, Liang B, Shirwany N, Zhu
Y and Zou MH: Activation of AMP-activated protein kinase is
required for berberine-induced reduction of atherosclerosis in
mice: The role of uncoupling protein 2. PLoS One. 6:e254362011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Palová-Jelínková L, Dáňová K, Drašarová H,
Dvořák M, Funda DP, Fundová P, Kotrbová-Kozak A, Černá M, Kamanová
J, Martin SF, et al: Pepsin digest of wheat gliadin fraction
increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-kB
signaling pathway and an NLRP3 inflammasome activation. PLoS One.
8:e624262013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Segovia J, Sabbah A, Mgbemena V, Tsai SY,
Chang TH, Berton MT, Morris IR, Allen IC, Ting JP and Bose S:
TLR2/MyD88/NF-kB pathway, reactive oxygen species, potassium efflux
activates NLRP3/ASC inflammasome during respiratory syncytial virus
infection. PLoS One. 7:e296952012. View Article : Google Scholar : PubMed/NCBI
|
